Global Blood Filters Market Share Is Expected to Grow At A CAGR Value Of Around 3.01% By 2028

02-Jun-2022 | Facts and Factors

According to Facts and Factors, the Global Blood Filters Market was valued at USD 381.05 million in 2021 and is predicted to increase at a CAGR of 3.01% to USD 424.06 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries.

The rising prevalence of blood-transfusion-related ailments such as anemia, sickle cell disease, bleeding disorders such as hemophilia, and cancer, among others, is driving up market value. The growing number of individuals suffering from chronic kidney disease (CKD) is driving up the demand for blood filtering devices. CKD is frequently caused by high blood pressure and does not improve with time; it hinders normal kidney function and necessitates dialysis, which helps to filter and cleanse the blood with the assistance of an external machine.

Browse the full “Blood Filters Market By Product (40 Microns and 70 Microns, 100 Microns and 170 Microns, Others), By Material (Polycarbonate, Polyester, ABS), By Application (Blood Processing, Blood Transfusion), By End-User (Blood Banks, Hospitals, Others), and By Region - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast 2022 – 2028"  report at https://www.fnfresearch.com/blood-filters-market

Since persons with kidney disease, transplant recipients, and other severe chronic medical conditions are at increased risk of contracting coronavirus, the global pandemic combined-19 is increasing market value. As people's immune systems deteriorate, it becomes more difficult for them to fight infections, thus it is critical that they continue with their regularly scheduled dialysis treatments. Furthermore, the key companies' continued attempts to minimize the cost of procedures are expected to provide significant opportunities during the forecast period. On the other hand, the risk and high expense connected with the practice of blood transfusion are expected to impede growth to some extent during the forecast period.

In terms of end-users, in the forecast period, hospitals held the greatest market share, accounting for a major share of the total. The increased occurrences of trauma and accident cases in hospitals can be ascribed to the segment's rise. In hospitals, blood transfusion filters are used to check for blood clots and other contaminants. They increase the safety of an operation that would otherwise be considered risky because of the possibility of infection or transmission of diseases such as hepatitis C, syphilis, HIV/AIDS, and Creutzfeldt-Jakob disease (CJD).

In terms of Application, the blood transfusion sector would have the biggest market share in the forecast period, and this dominance is predicted to continue throughout the projection period. The rising prevalence of blood-related ailments such as hemophilia, cancer, thrombocytopenia, and others, as well as chronic kidney disease (CKD), has increased the demand for total blood transfusion.

The Asia Pacific is expected to be a lucrative market for blood filters. Rapid economic development in India, China, and other Asian countries have increased healthcare expenditure and affordability for better healthcare items like blood filters. Increased hospitalization due to the increased frequency of heart problems, as well as the rising prevalence of chronic diseases driving the number of surgical procedures in the country, are important factors expected to drive the blood filter market over the forecast period. The rapid expansion is owing to constant initiatives by governments and non-governmental organizations (NGOs) in emerging countries to raise awareness about blood donation, as well as the presence of a huge population suffering from serious blood disorders.

Report Scope

Some of the major companies operating in the global blood filters market are Asahi Kasei Corporation, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, Infomed SA, KANEKA CORPORATION, Kawasumi laboratories. Inc., Sefar AG, Shandong Zhongbaokang, Medical Implements Co., Ltd., Nanjing Shuangwei Biotechnology Co., Ltd.,  and others.

The global blood filters market is segmented as follows:

By Product

• 40 Microns and 70 Microns
• 100 Microns and 170 Microns
• Others

By Material

• Polycarbonate
• Polyester
• ABS
• Others

By Application

• Blood Processing
• Blood Transfusion

By End-User

• Blood Banks
• Hospitals
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com